SEC EDGAR — 8-K filingsUnited States14 October 2026
8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR — 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-10-14 AccNo: 0001193125-26-421079 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR — 8-K filings
- 8-K/A - Palomino Laboratories Inc. (0001938569) (Filer)14 October 2026
- 8-K - Valaris Ltd (0000314808) (Filer)14 October 2026
- 8-K - TECOGEN INC. (0001537435) (Filer)14 October 2026
- 8-K - KiNRG, Inc. (0000095572) (Filer)14 October 2026
- 8-K - ProText Mobility, Inc. (0001163573) (Filer)14 October 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.